A prospective evaluation of pulmonary, cardiac, and hepatic function (fn) in ‘tAnGo’: A randomized phase III trial of gemcitabine (G) in paclitaxel (T)-containing, epirubicin/cyclophosphamide ...

Conclusion: AT significantly improves TTP and ORR compared with AC in patients with MBC, but there is no difference in OS. AT represents a valid option for the treatment of MBC. From the University of ...

Dr. Lisa Carey answers the question: 'Drugs, Schedules For Chemo Treatments?' — -- Question: What kinds of drugs, timetables and possible side effects can be expected with the following commonly ...

One method for increasing dose intensity in high risk patients in order to achieve the most benefit of maximum dose intensity is reducing the conventional drug dose intervals dose-dense regimen.

Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT) today announced that results of a clinical trial ...

Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk ...

San Antonio, TX – December 5, 2003 – A Docetaxel (Taxotere®)-based regimen reduced the relative risk of death in women with early stage breast cancer by 30 percent and lowered the relative risk of the ...

September 16, 2008 (Stockholm, Sweden) — The addition of docetaxel (Taxotere, Sanofi Aventis) to a traditional anthracycline-based regimen significantly improved both relapse-free survival and overall ...

Pictured below is a woman with microscopic polyangiitis treated with intravenous cyclophosphamide and high doses cytoxan price in india corticosteroids. After several cyclophosphamide treatments. When ...